Bruce I. Sachs, Director of Vertex Pharmaceuticals VRTX, has filed 2 purchases and 10 sales on the open market. The latest trade was on 05/01.

BS

BS

Bruce I. Sachs

Director

Company

Vertex Pharmaceuticals VRTX

First filing

23/01/18

Trades

43 trades

Buys / sales

2 / 10

12-month net buying

No record

Last trade

05/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Vertex PharmaceuticalsVRTX	Open-market buy	25/08/06	25/08/07	5,000 sh2 trades	$389.68avg.	$1,948,415.68	+12.5%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/08/01	24/08/02	5,295 sh	$508.00	$2,689,860	−11.7%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/05/22	24/05/24	7,073 sh	$448.00	$3,168,704	−15.0%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/11/06	23/11/08	11,250 sh	$385.00	$4,331,250	−22.0%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/07/17	23/07/18	11,250 sh3 trades	$356.75avg.	$4,013,458.81	−22.0%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/04/12	23/04/14	21,300 sh3 trades	$326.73avg.	$6,959,421.75	−34.1%
Vertex PharmaceuticalsVRTX	Open-market sale	23/01/31	23/02/02	1,200 sh	$325.01	$390,012	−2.8%